On November 1, 2023 at the 11th International mRNA Health Conference in Berlin, Germany, it is announced that 31 big pharma entities, from biotechnology, biopharma and life science companies and educational institutions come together to launch the lobby group called the Alliance for mRNA Medicines (AMM),”dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines…” globally. [1]
